Acute Coronary Syndromes

Acute coronary syndrome (ACS) is most commonly caused by a heart attack (myocardial infarction) where blood flow to the heart is suddenly blocked. This is usually caused by a blood clot from a ruptured coronary artery atherosclerotic plaque. Other causes include spontaneous coronary artery dissection (SCAD), which most commonly occurs in women. ACS is usually treated in a cath lab with angioplasty and the placement of a stent to prop the vessel open.

Plant-based diets linked to lower risks of death, heart disease, stroke and diabetes
Diets that prioritize plant-based foods are associated with several health benefits, according to a new study of more than 3.4 million adults. Such diets also show potential to reduce greenhouse gas emissions.
Beta blockers ‘have no effect’ on heart attack patients
One researcher described the study's findings as "one of the most significant advances in heart attack treatment in decades.”
New hypertension guidelines embrace early treatment, updated risk assessments and renal denervation
New ACC/AHA recommendations encourage clinicians to take a proactive approach when managing patients with elevated or high blood pressure. The inclusion of renal denervation in this document represents clear progress for a relatively new technology.
Gene discovery highlights connection between the kidneys and cardiovascular disease
“Our findings reveal how changes in cell metabolism and increased oxidative stress can activate damaging pathways in blood vessels," explained Xiaofeng Yang, MD, a researcher at Temple University.
Coronary sinus reducer linked to improvements in patients with refractory angina—but questions remain
Treatment with the device is consistently safe, but researchers still think more data is required before reaching any conclusions about its efficacy.

diet nuts legumes vegetables vegan vegetarian plant-based

Plant-based diets linked to lower risks of death, heart disease, stroke and diabetes

Diets that prioritize plant-based foods are associated with several health benefits, according to a new study of more than 3.4 million adults. Such diets also show potential to reduce greenhouse gas emissions.

Beta blockers ‘have no effect’ on heart attack patients

One researcher described the study's findings as "one of the most significant advances in heart attack treatment in decades.”

cardiologist doctor physician patient black diverse hypertension

New hypertension guidelines embrace early treatment, updated risk assessments and renal denervation

New ACC/AHA recommendations encourage clinicians to take a proactive approach when managing patients with elevated or high blood pressure. The inclusion of renal denervation in this document represents clear progress for a relatively new technology.

Gene discovery highlights connection between the kidneys and cardiovascular disease

“Our findings reveal how changes in cell metabolism and increased oxidative stress can activate damaging pathways in blood vessels," explained Xiaofeng Yang, MD, a researcher at Temple University.

coronary sinus reducer shockwave medical

Coronary sinus reducer linked to improvements in patients with refractory angina—but questions remain

Treatment with the device is consistently safe, but researchers still think more data is required before reaching any conclusions about its efficacy.

weight loss scale overweight obese lose weight pounds

Another win for Lilly: Oral GLP-1 drug linked to significant weight loss, other cardiovascular benefits

Tirzepatide and semaglutide are getting the attention now, but orforglipron could be the next go-to drug for patients hoping to lose weight and improve their heart health—no injections required.

Boston Scientific’s Agent Drug-Coated Balloon (DCB), which delivers a therapeutic dose of the anti-proliferative drug paclitaxel to the patient’s scar tissue to prevent ISR from recurring, gained FDA approval on March 1..

Boston Scientific’s coronary DCB gains new Medicare reimbursement

The first coronary DCB to gain FDA approval just received an additional reimbursement that could improve patient access.

Pilot study looks at same-day discharge PCI for acute coronary syndromes

Study shows same-day discharge is feasible for carefully selected, uncomplicated ACS patients.